FDA letter monthly archive

FDA Letters Issued in April 2018

Name: FDA Letters Issued in April 2018
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in April 2018. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Pfizer Inc. (Apr 20, 2018)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Chemistry, manufacturing, and controls, Safety and adverse events. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedApr 20, 2018
US FDA• TRAZIMERA

Complete Response Letter Pfizer Inc. (Apr 20, 2018)